Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone marrow—may help explain why people with inflammatory bowel disease (IBD) have a ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

A molecule produced by cancer cells can shield the brain from Alzheimer’s disease in mice. For decades, researchers have ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be.

An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers.

New melanoma immunotherapy research reveals how changing the way tumors die can awaken immune defenses and improve outcomes in mice.

Measles cases are surging in the U.S., partly fueled by claims that infection boosts immunity or fights cancer. Here’s what ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

A gynecologic oncologist at NYU Langone Health who treats patients with cervical cancer shares the warning signs she looks ...